NCT00587210View on ClinicalTrials.gov

Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Crohn Disease
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT00587210 - Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel | Biotech Hunter | Biotech Hunter